Skip to main content
Medicamen Biotech Ltd. logo

Medicamen Biotech Ltd. — Investor Relations & Filings

Ticker · MEDICAMEQ ISIN · INE646B01010 LEI · 894500T0ULD27B7W4Y03 BSE.NS Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2023-01-24 Regulatory Filings
Country IN India
Listing BSE.NS MEDICAMEQ

About Medicamen Biotech Ltd.

https://www.medicamen.com/

Medicamen Biotech Ltd. specializes in the research, development, and manufacturing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities compliant with international quality standards, including WHO-GMP. Its product portfolio encompasses various therapeutic segments such as oncology, cardiology, central nervous system, and anti-infectives, delivered through dosage forms like tablets, capsules, and liquid orals. A significant strategic focus is placed on its specialized oncology division, which develops complex generic formulations. The company serves global markets, leveraging its research and development capabilities to provide high-quality healthcare solutions. Its operations are supported by dedicated R&D centers focused on formulation development and process chemistry.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance notice under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the issuance of duplicate share certificates due to lost certificates. It is an official regulatory announcement related to share certificates but does not contain financial data, management discussion, or report content. The document is short (1535 characters) and serves as a regulatory compliance notification rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-01-24 English
Updates
Management Reports Classification · 95% confidence The document is titled 'Annual Communique-2023' and is addressed to stock exchanges with company codes, indicating it is an official communication to shareholders and regulators. The content includes a detailed letter from the Chairman discussing company performance, investments, product registrations, and future plans. It includes financial figures and operational updates but does not contain formal financial statements or comprehensive financial data typical of an Annual Report (10-K). The document is over 10,000 characters, so it is not a brief announcement or a report publication notice. It is a detailed management communication to shareholders about company progress and outlook, which aligns best with a Management Report (MDA) rather than a full Annual Report or Earnings Release. Therefore, the classification is Management Reports (MDA).
2022-12-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 30, 2022, addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the financial results announcement for the quarter ended December 31, 2022. It mentions compliance with insider trading regulations and states that the date of the board meeting for declaring financial results will be intimated later. The document does not contain any financial data, results, or detailed report content. It is an announcement related to the timing of financial results disclosure and trading restrictions, not the financial report itself. Given the short length (1394 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim Report or Earnings Release.
2022-12-30 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance notice under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the issuance of duplicate share certificates due to lost certificates. It is an official regulatory announcement related to share certificates but does not contain financial data, management discussion, or report content. It is not a report or financial statement but a regulatory compliance filing. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement, not a report itself.
2022-12-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a short compliance notice under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about the issuance of duplicate share certificates due to lost certificates. It is an official regulatory announcement related to share certificates but does not contain financial data, management discussion, or detailed report content. The document length is only 1450 characters, indicating it is a brief announcement rather than a full report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-12-29 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It covers related party transactions on a consolidated basis for the half year ended September 30, 2022. The document includes detailed tables of transactions, approval status, and financial values for the reporting period. It is not a full financial report like an Annual Report or Interim Report, nor is it an announcement of voting results or a management change. It is a regulatory disclosure specific to related party transactions, which fits best under the category of Regulatory Filings (RNS) as it is a compliance document required by the stock exchanges and SEBI regulations. The document length (7499 characters) and content confirm it is a substantive disclosure rather than a brief announcement or certification.
2022-11-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.